Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.10.0.1
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2018
Aug. 03, 2018
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2018  
Entity Registrant Name REXAHN PHARMACEUTICALS, INC.  
Entity Central Index Key 0001228627  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q2  
Trading Symbol rnn  
Entity Common Stock, Shares Outstanding   31,751,939